Maloney, D G <br/><br/>
IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Oct 1997 
 - 3266-74 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1997.15.10.3266  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>Disease Progression<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Immunoglobulins--analysis<br/>Immunotherapy<br/>Infusions, Intravenous<br/>Lymphocyte Subsets<br/>Lymphoma, B-Cell--immunology<br/>Male<br/>Middle Aged<br/>Recurrence<br/>Rituximab